Log in to save to my catalogue

Targeting calcitonin gene-related peptide: a new era in migraine therapy

Targeting calcitonin gene-related peptide: a new era in migraine therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2310723171

Targeting calcitonin gene-related peptide: a new era in migraine therapy

About this item

Full title

Targeting calcitonin gene-related peptide: a new era in migraine therapy

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2019-11, Vol.394 (10210), p.1765-1774

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Migraine is one of the most prevalent and disabling diseases worldwide, but until recently, few migraine-specific therapies had been developed. Extensive basic and clinical scientific investigation has provided strong evidence that the neuropeptide calcitonin gene-related peptide (CGRP) has a key role in migraine. This evidence led to the developme...

Alternative Titles

Full title

Targeting calcitonin gene-related peptide: a new era in migraine therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2310723171

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2310723171

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(19)32504-8

How to access this item